Be Ready to Manage Patients on Palforzia for Peanut Allergy

Palforzia, the first FDA-approved option for peanut allergy desensitization, will pop up on some home med lists.

It doesn't allow patients to freely eat peanut products. But it may minimize an allergic reaction from accidental exposure.

Palforzia is a peanut allergen powder given orally in increasing doses to patients 4 to 17 years old.

Get concise advice on drug therapy, plus unlimited access to CE

Hospital Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote